Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peter pan homolog (PPAN) is an evolutionarily conserved protein in humans encoded by the PPAN gene, with homology to yeast SSF1 and the Drosophila Peter Pan gene[1][3][10]. PPAN is essential for cell growth and proliferation and participates in ribosome biogenesis as a Brix domain-containing protein. It is involved in mRNA splicing (especially the second step), mitochondrial homeostasis (through modulation of autophagy), and regulation of apoptosis[1]. Depletion of PPAN leads to increased apoptosis, cell cycle arrest, and upregulation of p53 and its targets. The gene has ubiquitous expression, and its exogenous expression can reduce the anchorage-independent growth of certain tumor cells. Disease association has been noted with narcolepsy and cancer, reflecting its importance in cellular proliferation and differentiation[7][1][10]. There are currently no known drugs, biomarkers, or direct safety considerations linked to therapeutic targeting of PPAN.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peter pan homolog (PPAN).